chr9-128959121-A-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_015354.3(NUP188):​c.572A>G​(p.His191Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000623 in 1,445,246 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000062 ( 0 hom. )

Consequence

NUP188
NM_015354.3 missense

Scores

2
1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.98

Publications

0 publications found
Variant links:
Genes affected
NUP188 (HGNC:17859): (nucleoporin 188) The nuclear pore complex (NPC) is found on the nuclear envelope and forms a gateway that regulates the flow of proteins and RNAs between the cytoplasm and nucleoplasm. The NPC is comprised of approximately 30 distinct proteins collectively known as nucleoporins. Nucleoporins are pore-complex-specific glycoproteins which often have cytoplasmically oriented O-linked N-acetylglucosamine residues and numerous repeats of the pentapeptide sequence XFXFG. However, the nucleoporin protein encoded by this gene does not contain the typical FG repeat sequences found in most vertebrate nucleoporins. This nucleoporin is thought to form part of the scaffold for the central channel of the nuclear pore. [provided by RefSeq, Jan 2013]
NUP188 Gene-Disease associations (from GenCC):
  • sandestig-stefanova syndrome
    Inheritance: AR, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.09592253).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NUP188NM_015354.3 linkc.572A>G p.His191Arg missense_variant Exon 8 of 44 ENST00000372577.2 NP_056169.1 Q5SRE5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NUP188ENST00000372577.2 linkc.572A>G p.His191Arg missense_variant Exon 8 of 44 1 NM_015354.3 ENSP00000361658.2 Q5SRE5-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000125
AC:
3
AN:
240298
AF XY:
0.0000154
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000909
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000623
AC:
9
AN:
1445246
Hom.:
0
Cov.:
30
AF XY:
0.00000557
AC XY:
4
AN XY:
718602
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32718
American (AMR)
AF:
0.00
AC:
0
AN:
42722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25672
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39182
South Asian (SAS)
AF:
0.0000121
AC:
1
AN:
82780
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52842
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5686
European-Non Finnish (NFE)
AF:
0.00000634
AC:
7
AN:
1104092
Other (OTH)
AF:
0.0000168
AC:
1
AN:
59552
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.531
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Jun 04, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.572A>G (p.H191R) alteration is located in exon 8 (coding exon 8) of the NUP188 gene. This alteration results from a A to G substitution at nucleotide position 572, causing the histidine (H) at amino acid position 191 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
20
DANN
Benign
0.94
DEOGEN2
Benign
0.034
T
Eigen
Benign
-0.11
Eigen_PC
Benign
0.075
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.81
T
M_CAP
Benign
0.0082
T
MetaRNN
Benign
0.096
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.55
N
PhyloP100
7.0
PrimateAI
Uncertain
0.74
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.088
Sift
Benign
0.091
T
Sift4G
Pathogenic
0.0
D
Polyphen
0.0010
B
Vest4
0.16
MutPred
0.59
Gain of MoRF binding (P = 0.0162);
MVP
0.14
MPC
0.23
ClinPred
0.45
T
GERP RS
4.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.13
gMVP
0.63
Mutation Taster
=69/31
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs762740256; hg19: chr9-131721400; API